Media Update: Sanofi completes closing for potential first-in-class vaccine against extraintestinal pathogenic E.coli (ExPEC)

https://ift.tt/aoFfXNw

 

from Sanofi - Aventis Groupe https://ift.tt/nkCVeNr
via IFTTT